Joint Chiefs Urge “Due Diligence” in Targeting the Enemy
The proper selection and validation of enemy targets in war is a critical function for military planners and intelligence analysts. Errors can result in horrific civilian casualties and may also be strategically counterproductive.
“In extreme cases, failure to exercise due diligence in target development can result in outcomes that have negative strategic repercussions for the United States and its allies,” a newly disclosed Pentagon manual on targeting acknowledges (in bold type).
Procedures for correctly identifying and approving targets are described in the manual. See Target Development Standards, Chairman of the Joint Chiefs of Staff Instruction 3370.01B, 230 pages, 6 May 2016 (Unclassified, For Official Use Only).
A target is “an entity or object that performs a function for the adversary considered for possible engagement or other action,” the manual explains.
“Targets fall into one of five target types: facility, individual, virtual, equipment, or organization.”
“Examples include POL [petroleum, oil or lubricant] or PWR [electric power] sites (facilities), the chief accountant of a terrorist group (individual), a Web site (virtual), mobile radar (equipment), or a motorized infantry brigade (organization).”
“A terrorist network is the adversary, not a target. A front company (an entity) that ships lethal aid (a function) for the terrorist network (the adversary) would be a target.”
“Collateral effects are unintentional or incidental adverse consequences of target engagement. Such effects are not unlawful so long as it is not excessive in light of the overall military advantage anticipated from the engagement.”
“While all targets are entities, not all entities in the battlespace are valid targets. To be validated as a target, the function of the entity must be tied to commander’s objectives (operationally relevant) and meet Law of War (LOW) requirements,” the manual notes.
The manual applies to the Department of Defense and the military services. It does not govern lethal operations by the Central Intelligence Agency.
Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.
“Given the number of existential crises we must collectively confront, I have found policy entrepreneurship to be a fruitful avenue towards doing some of that work.”
We sit on the verge of another Presidential election – an opportunity for meaningful, science-based policy innovations that can appeal to lawmakers on both sides of the aisle.
Outdated Bureau of Labor Statistics classifications hampers the federal government’s ability to design and implement effective policies for emerging technologies sectors.